Clinical trial
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable…
NCT00107419 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00107419 |
|---|---|
| Title | S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma |
| Official title | Phase II Trial of Pemetrexed for Advanced Chondrosarcomas |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | pemetrexed disodium |
| Enrollment | 75 |
| Start date | Sep 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | Aug 1, 2009 |
| First posted | Apr 6, 2005 |
| Last update posted | Jan 18, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: